NCT04200807

Brief Summary

Non-invasively neonatal cardiac output can be measured by multiple methods, but the gold standard still remains conventional echocardiography. It is accurate, but needs a long training for new users to assess cardiac function. Continuous-wave Doppler ultrasound monitor USCOM is a relatively new monitor which can perform faster and less complex cardiac function measurement, also it is easier for the operator to get trained. The aim of the study is to assess the level of agreement between cardiac output measured with conventional echocardiography and with USCOM, to present normal ranges for neonates of different gestational age and to look for early signs of hemodynamic changes during sepsis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
163

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2017

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 12, 2017

Completed
2.2 years until next milestone

First Submitted

Initial submission to the registry

November 18, 2019

Completed
28 days until next milestone

First Posted

Study publicly available on registry

December 16, 2019

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2020

Completed
Last Updated

April 21, 2021

Status Verified

September 1, 2020

Enrollment Period

3.1 years

First QC Date

November 18, 2019

Last Update Submit

April 20, 2021

Conditions

Keywords

cardiac output; echocardiography; USCOM; neonates

Outcome Measures

Primary Outcomes (9)

  • Weight measurement

    weight in grams

    1 minute

  • Height measurement

    length in centimeters

    1 minute

  • Chest and head circumference

    Chest and head circumference in centimeters

    1 minute

  • Blood pressure measurement

    non- invasive arterial blood pressure measurement in mmHg

    1 minute

  • Pulse rate measurement

    pulse rate in beats per minute

    1 minute

  • Near- Infrared Spectroscopy for regional blood flow

    One sensor on the forehead, another- on the back to check for regional blood flow in the brain and kidney with Near- Infrared Spectroscopy

    15-20 minutes

  • Echocardioscopy for left ventricular outflow tract diameter

    Echocardiography for left ventricular outflow tract diameter in centimeters

    2-3 minutes

  • Echocardioscopy to measure velocity time integral

    Echocardiography to measure velocity time integral at the aortic valve in centimeters. After that the software of the device calculates cardiac output.

    3 minutes

  • USCOM examination

    USCOM 1A uses continuous wave Doppler for flow curves, which are obtained at the suprasternal notch for an optimal flow signal at the aortic valve. The software of the device calculates cardiac output then

    3-5 minutes

Study Arms (3)

Healthy preterm neonate

Neonate 26 weeks to 36 weeks + 6 days of gestation, without congenital heart defects and/or hemodynamically significant fetal circulation, any respiratory therapy, nor need of supplemental oxygen. Subjects had no clinically and laboratory-identified infections.

Device: Ultrasound Cardiac Output Monitor (USCOM 1A)

Healthy term neonate

Neonate from 37 weeks of gestation, without congenital heart defects and/or hemodynamically significant fetal circulation, any respiratory therapy, nor need of supplemental oxygen. Subjects had no clinically and laboratory-identified infections.

Device: Ultrasound Cardiac Output Monitor (USCOM 1A)

Sick neonate

Neonate of any gestation, without congenital heart defects, with clinically and laboratory-identified infection.

Device: Ultrasound Cardiac Output Monitor (USCOM 1A)

Interventions

doplerometry with USCOM and echocardiograph is made for assessing central blood flow and spectroscopy with NONIN- for the blood flow in individual peripheral organs (brain and kidney)

Also known as: GE LOGIQ S8 XDclear 2.0 ultrasound system with S4-10-D (3-9MHz) probe, NONIN Equanox near-infrared spectroscope
Healthy preterm neonateHealthy term neonateSick neonate

Eligibility Criteria

Age26 Weeks - 44 Weeks
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

The study enrolled both preterm and full-term newborns of any gestational age, without congenital heart defects and/or hemodynamically significant fetal circulation, any respiratory therapy, nor need of supplemental oxygen. Subjects had no clinically and laboratory-identified infections in control group.

You may qualify if:

  • newborns of any gestational age
  • parental consent acquired

You may not qualify if:

  • congenital malformations
  • hemodynamic instability in control group
  • any respiratory support in control group
  • infection in control group

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Vilnius University, Neonatology Centre

Vilnius, 08464, Lithuania

Location

Related Publications (1)

  • Pliauckiene A, Liubsys A, Vankeviciene R, Usonis V. Ultrasonic cardiac output monitor provides effective non-invasive bedside measurements of neonatal cardiac output. J Clin Monit Comput. 2022 Jun;36(3):803-807. doi: 10.1007/s10877-021-00711-2. Epub 2021 Apr 30.

MeSH Terms

Conditions

Premature Birth

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

  • Vytautas Usonis, MD

    Vilnius University

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 18, 2019

First Posted

December 16, 2019

Study Start

September 12, 2017

Primary Completion

September 30, 2020

Study Completion

September 30, 2020

Last Updated

April 21, 2021

Record last verified: 2020-09

Locations